Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Eli Lilly & Co.    LLY   US5324571083

ELI LILLY & CO.

 (LLY)

21
SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisionsForum 

Eli Lilly & Co. : Lilly Confirms Date and Conference Call for Second-Quarter 2012 Financial Results Announcement

07/12/2012| 04:05pm US/Eastern
Recommend:
0

INDIANAPOLIS, July 12, 2012 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2012 on Wednesday, July 25, 2012. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance.

The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at www.lilly.com. A replay will also be available on the website following the conference call.

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com. F-LLY

(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO )

SOURCE Eli Lilly and Company

Recommend :
0
Partner Area
React to this article
 
Latest news on ELI LILLY & CO.
3d ago Amazon gets help to lure big business to the cloud
4d ago ELI LILLY & CO.: Lilly Oncology to Release New Pipeline Data at ASCO 2013
4d agoDJELI LILLY & CO.: Lilly CEO Recovering From Surgery for Dilated Aorta
4d ago ELI LILLY & CO.: Lilly Provides Update on CEO Dr. John Lechleiter
4d ago ELI LILLY & CO.: ex-dividend day
05/10 Drugmakers face more scrutiny of discordant U.S. prices
05/10DJELI LILLY & CO.: Eli Lilly Ends Development of Lymphoma Drug Enzastaurin; Misse..
05/10 ELI LILLY & CO.: Lilly Announces Enzastaurin Phase III Study Did Not Meet Prima..
05/06DJLilly CEO to Have Artery Surgery, Seen Returning by Fall
05/06DJLilly CEO to Have Artery Surgery, Seen Returning By Fall
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.